DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 27, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 14, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 25, 2022 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
Gates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement Post author:GHIAA Admin Post published:August 11, 2022 Post category: Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:April 12, 2022 Post category: Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement
Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:March 3, 2022 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement